Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-7.9%/yr
vs +12.3%/yr prior
5Y CAGR
-6.8%/yr
Consistent
Acceleration
-20.2pp
Decelerating
Percentile
P69
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $108.38M | +1.7% |
| 2024 | $106.55M | +6.3% |
| 2023 | $100.23M | -27.7% |
| 2022 | $138.60M | -20.4% |
| 2021 | $174.14M | +13.0% |
| 2020 | $154.10M | +3.1% |
| 2019 | $149.46M | +71.7% |
| 2018 | $87.06M | +222.4% |
| 2017 | $27.01M | +21.6% |
| 2016 | $22.21M | - |